Application Nr Approved Date Route Status External Links
NDA021379 2002-07-24 Subcutaneous RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Eligard® Is Indicated For The Palliative Treatment Of Advanced Prostate Cancer. Eligard® Is A Gonadatropin Releasing Hormone (gnrh) Agonist Indicated For The Palliative Treatment Of Advanced Prostate Cancer (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Leuprolide Acetate

Comments